These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17140277)

  • 21. Efficacy of levetiracetam in partial seizures.
    Devinsky O; Elger C
    Epileptic Disord; 2003 May; 5 Suppl 1():S27-31. PubMed ID: 12915338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for a rapid action of levetiracetam compared to topiramate in refractory partial epilepsy.
    Specchio LM; Boero G; Specchio N; De Agazio G; De Palo A; de Tommaso M; Beghi E; La Neve A
    Seizure; 2006 Mar; 15(2):112-6. PubMed ID: 16406697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Newer therapies in the drug treatment of epilepsy.
    McAuley JW; Biederman TS; Smith JC; Moore JL
    Ann Pharmacother; 2002 Jan; 36(1):119-29. PubMed ID: 11816240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic evaluation of levetiracetam as an add-on therapy in patients with refractory epilepsy.
    Blais L; Sheehy O; St-Hilaire JM; Bernier G; Godfroid P; LeLorier JJ
    Pharmacoeconomics; 2005; 23(5):493-503. PubMed ID: 15896100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three new drugs for epilepsy: levetiracetam, oxcarbazepine, and zonisamide.
    Leppik IE
    J Child Neurol; 2002 Jan; 17 Suppl 1():S53-7. PubMed ID: 11918464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levetiracetam in childhood epilepsy.
    Verrotti A; D'Adamo E; Parisi P; Chiarelli F; Curatolo P
    Paediatr Drugs; 2010 Jun; 12(3):177-86. PubMed ID: 20486734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Review on Pharmacokinetics of Levetiracetam in Neonates.
    Agrawal A; Banergee A
    Curr Drug Metab; 2017 Oct; 18(8):727-734. PubMed ID: 28595534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of levetiracetam.
    Radtke RA
    Epilepsia; 2001; 42 Suppl 4():24-7. PubMed ID: 11564121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levetiracetam as adjunctive therapy for refractory anxiety disorders.
    Kinrys G; Worthington JJ; Wygant L; Nery F; Reese H; Pollack MH
    J Clin Psychiatry; 2007 Jul; 68(7):1010-3. PubMed ID: 17685735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Are clinical features derived from evidences and experiences outside of Japan applicable to clinical practices in Japan? Comparisons of results among studies conducted in US, Europe, Asian Countries and Japan].
    Kamada K
    Brain Nerve; 2011 Mar; 63(3):247-54. PubMed ID: 21386126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefit-risk assessment of levetiracetam in the treatment of partial seizures.
    Abou-Khalil B
    Drug Saf; 2005; 28(10):871-90. PubMed ID: 16180937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety profile of levetiracetam.
    Arroyo S; Crawford P
    Epileptic Disord; 2003 May; 5 Suppl 1():S57-63. PubMed ID: 12915343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of levetiracetam: a review of three pivotal clinical trials.
    Privitera M
    Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levetiracetam for seizure prevention in brain tumor patients: a systematic review.
    Nasr ZG; Paravattil B; Wilby KJ
    J Neurooncol; 2016 Aug; 129(1):1-13. PubMed ID: 27168191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacokinetic characteristics of levetiracetam.
    Patsalos PN
    Methods Find Exp Clin Pharmacol; 2003 Mar; 25(2):123-9. PubMed ID: 12731458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of randomized trials on first line and adjunctive levetiracetam.
    Lo BW; Kyu HH; Jichici D; Upton AM; Akl EA; Meade MO
    Can J Neurol Sci; 2011 May; 38(3):475-86. PubMed ID: 21515509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
    Li S; Cao J; Xiao N; Cai F
    J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
    Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
    Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.